收费全文 | 47719篇 |
免费 | 3847篇 |
国内免费 | 115篇 |
耳鼻咽喉 | 393篇 |
儿科学 | 1926篇 |
妇产科学 | 1314篇 |
基础医学 | 6829篇 |
口腔科学 | 987篇 |
临床医学 | 6562篇 |
内科学 | 9238篇 |
皮肤病学 | 896篇 |
神经病学 | 4845篇 |
特种医学 | 1082篇 |
外科学 | 4219篇 |
综合类 | 411篇 |
一般理论 | 62篇 |
预防医学 | 5835篇 |
眼科学 | 673篇 |
药学 | 2671篇 |
2篇 | |
中国医学 | 54篇 |
肿瘤学 | 3682篇 |
2024年 | 60篇 |
2023年 | 424篇 |
2022年 | 585篇 |
2021年 | 1268篇 |
2020年 | 942篇 |
2019年 | 1409篇 |
2018年 | 1543篇 |
2017年 | 1207篇 |
2016年 | 1340篇 |
2015年 | 1413篇 |
2014年 | 1796篇 |
2013年 | 2644篇 |
2012年 | 3680篇 |
2011年 | 3803篇 |
2010年 | 2085篇 |
2009年 | 1841篇 |
2008年 | 3068篇 |
2007年 | 3158篇 |
2006年 | 3122篇 |
2005年 | 2928篇 |
2004年 | 2843篇 |
2003年 | 2603篇 |
2002年 | 2343篇 |
2001年 | 390篇 |
2000年 | 285篇 |
1999年 | 326篇 |
1998年 | 525篇 |
1997年 | 400篇 |
1996年 | 355篇 |
1995年 | 345篇 |
1994年 | 272篇 |
1993年 | 272篇 |
1992年 | 208篇 |
1991年 | 183篇 |
1990年 | 160篇 |
1989年 | 130篇 |
1988年 | 136篇 |
1987年 | 103篇 |
1986年 | 103篇 |
1985年 | 124篇 |
1984年 | 116篇 |
1983年 | 106篇 |
1982年 | 133篇 |
1981年 | 127篇 |
1980年 | 107篇 |
1979年 | 70篇 |
1978年 | 69篇 |
1977年 | 51篇 |
1976年 | 52篇 |
1973年 | 45篇 |
This study tested the hypothesis that progression of chronic kidney disease (CKD) is less aggressive in patients whose primary cause of CKD was nephrectomy, compared with non-surgical causes.
MethodsA sample of 5983 patients from five specialist nephrology practices was ascertained from the Queensland CKD Registry. Rates of kidney failure/death were compared on primary aetiology of CKD using multivariable Cox proportional hazards models. CKD progression was compared using multivariable linear and logistic regression analyses.
ResultsOf 235 patients with an acquired single kidney as their primary cause of CKD, 24 (10%) and 38 (17%) developed kidney failure or died at median [IQR] follow-up times of 12.9 [2.5–31.0] and 33.6 [18.0–57.9] months after recruitment. Among patients with an eGFR?<?45 mL/min per 1.73m2 at recruitment, patients with diabetic nephropathy and PCKD had the highest rates (per 1000 person-years) of kidney failure (107.8, 95% CI 71.0–163.8; 75.5, 95% CI 65.6–87.1); whereas, patients with glomerulonephritis and an acquired single kidney had lower rates (52.9, 95% CI 38.8–72.1; 34.6, 95% CI 20.5–58.4, respectively). Among patients with an eGFR?≥?45 mL/min per 1.73m2, those with diabetic nephropathy had the highest rates of kidney failure (16.6, 95% CI 92.5–117.3); whereas, those with glomerulonephritis, PCKD and acquired single kidney had a lower risk (11.3, 95% CI 7.1–17.9; 11.7, 95% CI 3.8–36.2; 10.7, 95% CI 4.0–28.4, respectively).
ConclusionPatients who developed CKD after nephrectomy had similar rates of adverse events to most other causes of CKD, except for diabetic nephropathy which was consistently associated with worse outcomes. While CKD after nephrectomy is not the most aggressive cause of kidney disease, it is by no means benign, and is associated with a tangible risk of kidney failure and death, which is comparable to other major causes of CKD.
相似文献Brain invasion has not been recognized as a standalone criterion for atypical meningioma by the WHO classification until 2016. Since the 2007 edition suggested that meningiomas harboring brain invasion could be classified as grade 2, brain invasion study was progressively strengthened in our center, based on a strong collaboration between neurosurgeons and neuropathologists regarding sample orientation and examination. Practice changes were considered homogeneous enough in 2011. The aim of the present study was to evaluate the impact of gross practice change on the clinical and pathological characteristics of intracranial meningiomas classified as grade 2.
The characteristics of consecutive patients with a grade 2 meningioma surgically managed before (1998–2005, n?=?125, group A) and after (2011–2014, n?=?166, group B) practices changed were retrospectively reviewed.
Sociodemographical and clinical parameters were comparable in groups A and B, and the median age was 62 years in both groups (p?=?0.18). The 5-year recurrence rates (23.2% vs 29.5%, p?=?0.23) were similar. In group A, brain invasion was present in 48/125 (38.4%) cases and was more frequent than in group B (14/166, 8.4%, p?<?0.001). In group A, 33 (26.4%) meningiomas were classified as grade 2 solely based on brain invasion (group ASBI), and 92 harbored other grade 2 criteria (group AOCA). Group ASBI meningiomas had a similar median progression-free survival compared to groups AOCA (68 vs 80 months, p?=?0.24) and to AOCA and B pooled together (n?=?258, 68 vs 90 months, p?=?0.42).
An accurate assessment of brain invasion is mandatory as brain invasion is a strong predictor of meningioma progression.
相似文献